Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 226 contracts
Samples: Securities Purchase Agreement (Clean Vision Corp), Securities Purchase Agreement (Clean Vision Corp), Securities Purchase Agreement (Kisses From Italy Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filingsPeriodic Report filings with the SEC, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 146 contracts
Samples: Securities Purchase Agreement (Recon Technology, LTD), Securities Purchase Agreement (Data443 Risk Mitigation, Inc.), Securities Purchase Agreement (Growlife, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 46 contracts
Samples: Securities Purchase Agreement (Friendable, Inc.), Securities Purchase Agreement (Friendable, Inc.), Securities Purchase Agreement (Sylios Corp)
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances circumstances, which might give rise to any of the foregoing.
Appears in 37 contracts
Samples: Securities Purchase Agreement (Propanc Biopharma, Inc.), Securities Purchase Agreement (NanoFlex Power Corp), Securities Purchase Agreement (Propanc Biopharma, Inc.)
Absence of Litigation. Except as disclosed to the Buyer or in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoingMaterial Adverse Effect.
Appears in 27 contracts
Samples: Securities Purchase Agreement (Propanc Biopharma, Inc.), Securities Purchase Agreement (Propanc Biopharma, Inc.), Securities Purchase Agreement (Propanc Biopharma, Inc.)
Absence of Litigation. Except as disclosed in the Company’s 's public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 14 contracts
Samples: Securities Purchase Agreement (Guided Therapeutics Inc), Securities Purchase Agreement (Vet Online Supply Inc), Securities Purchase Agreement (Stealth Technologies, Inc.)
Absence of Litigation. Except as disclosed set forth in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 12 contracts
Samples: Securities Purchase Agreement (NovAccess Global Inc.), Securities Purchase Agreement (Growlife, Inc.), Securities Purchase Agreement (NovAccess Global Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filingsset forth on Schedule 3(i), there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 8 contracts
Samples: Securities Purchase Agreement (Camelot Entertainment Group, Inc.), Securities Purchase Agreement (Camelot Entertainment Group, Inc.), Securities Purchase Agreement (Camelot Entertainment Group, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 6 contracts
Samples: Securities Purchase Agreement (uBid Holdings, Inc./New), Securities Purchase Agreement (uBid Holdings, Inc./New), Securities Purchase Agreement (Pura Naturals, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filings's Periodic Report filings with the SEC, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Cannasys Inc), Securities Purchase Agreement (U.S. Lithium Corp.), Securities Purchase Agreement (U.S. Lithium Corp.)
Absence of Litigation. Except as disclosed in the Company’s public filingsDisclosure Schedule hereto, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 6 contracts
Samples: Securities Purchase Agreement (HydroPhi Technologies Group, Inc.), Securities Purchase Agreement (HydroPhi Technologies Group, Inc.), Securities Purchase Agreement (HydroPhi Technologies Group, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filingsSEC Filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 5 contracts
Samples: Securities Purchase Agreement (Freeseas Inc.), Securities Purchase Agreement (Freeseas Inc.), Securities Purchase Agreement (Freeseas Inc.)
Absence of Litigation. Except as disclosed in Schedule 3(i-1), to the Company’s public filingsknowledge of the Company or any of its subsidiaries, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f3(i-2) contains a complete list and summary description of any known pending or, to the knowledge of the Company, or threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it it, if adversely decided, would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Universal Energy Corp.), Securities Purchase Agreement (Universal Energy Corp.), Securities Purchase Agreement (Universal Energy Corp.)
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effecteffect on the Company. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 3 contracts
Samples: Securities Purchase Agreement (C-Bond Systems, Inc), Securities Purchase Agreement (C-Bond Systems, Inc), Securities Purchase Agreement (C-Bond Systems, Inc)
Absence of Litigation. Except Other than as disclosed set forth in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Mphase Technologies Inc)
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-–regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances circumstances, which might give rise to any of the foregoing.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Lithium Exploration Group, Inc.), Securities Purchase Agreement (Lithium Exploration Group, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Material Adverse Effect, except as set forth in the SEC Documents.. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding (which would require disclosure on the Company’s SEC Documents) against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Jammin Java Corp.), Securities Purchase Agreement (Jammin Java Corp.)
Absence of Litigation. Except as disclosed in the Company’s public filings, there SEC Documents or Schedule 3(j),there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f) contains The SEC Documents contain a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Mobiquity Technologies, Inc.), Securities Purchase Agreement (Mobiquity Technologies, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list from the Company and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Hemp Naturals, Inc.), Securities Purchase Agreement (Hemp Naturals, Inc.)
Absence of Litigation. Except as otherwise disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Mphase Technologies Inc)
Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, other than disclosed in the SEC Documents, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Freeseas Inc.), Securities Purchase Agreement (Freeseas Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Except as disclosed on Schedule 3(i) the Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Xsovt Brands, Inc.), Securities Purchase Agreement (Xsovt Brands, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect except as set forth in the SEC Documents. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (Sanomedics International Holdings, Inc)
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing, except as disclosed in Schedule 3(f).
Appears in 1 contract
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f3(t) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (Guided Therapeutics Inc)
Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Material Adverse Effect , except as set forth in the SEC Documents.. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding (which would require disclosure on the Company’s SEC Documents) against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Absence of Litigation. Except as disclosed in the Company’s public filingspublicfilings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances circumstances, which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (IRONCLAD ENCRYPTION Corp)
Absence of Litigation. Except as disclosed in the Company’s public filingsfilings with the SEC, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) The Company’s public filings with the SEC contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (Rich Pharmaceuticals, Inc.)
Absence of Litigation. Except as disclosed to the Buyer or in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(t) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoingMaterial Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (Propanc Biopharma, Inc.)
Absence of Litigation. Except Other than as disclosed in the Company’s public filings, 's SEC Documents there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. To the extent not already disclosed in the SEC Documents, Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Absence of Litigation. Except Other than as disclosed in the Company’s public filingsset forth on Schedule 3(i), there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Absence of Litigation. Except as disclosed in the Company’s public filingsSchedule 3(i), there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Except as set forth in Schedule 3(i), the Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains The Company’s public filings contain a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (Rich Pharmaceuticals, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) The Company’s filings with the SEC contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (Rich Pharmaceuticals, Inc.)
Absence of Litigation. Except Other than as disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.)
Absence of Litigation. Except as disclosed in the Company’s ’ s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened tlu·eatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (NanoFlex Power Corp)
Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect (except with respect to the lawsuit brought against the Company by its previous controller). Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries involving estimated damages in excess of $200,000, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (Guided Therapeutics Inc)
Absence of Litigation. Except as disclosed in the Company’s public filingsSEC Documents, there tthere is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f) contains The public filings contain a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (TPT Global Tech, Inc.)
Absence of Litigation. Except Other than as disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesMaterial Subsidiaries, threatened against or affecting the Company or any of its subsidiariesMaterial Subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f) contains The SEC Documents contain a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effectMaterial Subsidiaries. The Company and its subsidiaries Material Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.)
Absence of Litigation. Except as disclosed in the Company’s 's public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances circumstances, which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (Cannabis Global, Inc.)
Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public is board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. effect The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (NanoFlex Power Corp)
Absence of Litigation. Except as disclosed set forth in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might could reasonably give rise to any of the foregoing.
Appears in 1 contract
Samples: Securities Purchase Agreement (EzFill Holdings Inc)
Absence of Litigation. Except as disclosed in Schedule 3(bb-1), to the Company’s public filingsbest knowledge of the Company or any of its subsidiaries, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the best knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f3(bb-2) contains a complete list and summary description of any known pending or, to the knowledge of the Company, or threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it it, if adversely decided, would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Appears in 1 contract
Absence of Litigation. Except as disclosed in the Company’s 's public filings, there is no action, suit, claim, proceeding, inquiry inquiry, or investigation before or by any court, public board, government agency, or self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which that might give rise to any of the foregoing.
Appears in 1 contract